Evaluation of surgical resection for gallbladder carcinoma at a Japanese Cancer Institute

Hepato-Gastroenterology

Volumn 59, Issue 118, 2012, Pages 1717-1721

  Nanashima, Atsushi ^a   Tobinaga, Syuuichi ^a   Abo, Takafumi ^a   Morisaki, Tomohito ^a   Uehara, Ryouhei ^a   Takeshita, Hiroaki ^a   Nonaka, Takashi ^a   Hidaka, Shigekazu ^a   Takeshima, Fuminao ^a   Ohnita, Ken ^a   Isomoto, Hajime ^a   Kunizaki, Masaki ^a   Sawai, Terumitsu ^a   Nakao, Kazuhiko ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Curability; Gallbladder carcinoma; Stage; Survival; Tumor markers

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; UFT;

ADULT; AGED; ARTICLE; BILE LEAKAGE; CANCER CENTER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CHOLECYSTECTOMY; CLINICAL ARTICLE; FEMALE; GALLBLADDER CARCINOMA; HEMIHEPATECTOMY; HUMAN; LIVER METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CELL DIFFERENTIATION; CHEMOTHERAPY, ADJUVANT; CHOLECYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84867705879     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge10299     Document Type: Article

References (28)

1. Miyazaki M, Takada T, Miyakawa S, et al.: Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors. J Hepatobiliary Pancreat Surg 2008; 15:15-24. (Pubitemid 351279837)
2. Chan SY, Poon RT, Lo CM, Ng KK, Fan ST: Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol 2008; 97:156-164. (Pubitemid 351169046)
3. Wakai T, Shirai Y, Tsuchiya Y, et al.: Combined major hepatectomy and pancreaticoduodenectomy for locally advanced biliary carcinoma: long-term results. World J Surg 2008; 32:1067-1074.
4. Yokomizo H, Yamane T, Hirata T, Hifumi M, Kawaguchi T, Fukuda S: Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol 2007; 14:1366-1373. (Pubitemid 46536809)
5. de Aretxabala X, Roa I, Burgos L, et al.: Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. J Gastrointest Surg 2006; 10:186-192. (Pubitemid 43187179)
6. Shimada H, Endo I, Togo S, Nakano A, Izumi T, Nakagawara G: The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 1997; 79:892-899. (Pubitemid 27089871)
7. Shirai Y, Wakai T, Hatakeyama K: Radical lymph node dissection for gallbladder cancer: indications and limitations. Surg Oncol Clin N Am 2007; 16:221-232.
8. Gold DG, Miller RC, Haddock MG, et al.: Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 2009; 75:150-155.
9. Japanese Society of Biliary Surgery (JSBS): In: Nagakawa T ed. Classification of Biliary Tract Carcinoma. Tokyo: Kanehara & Co., Ltd., 2004; 11-50.
10. Ehrenfried JA, Vauthey JN: Biliary tract cancer. Curr Opin Gastroenterol 1999; 15:430-435. (Pubitemid 29390432)
11. Wakai T, Shirai Y, Yokoyama N, Ajioka Y, Watanabe H, Hatakeyama K: Depth of subserosal invasion predicts long-term survival after resection in patients with T2 gallbladder carcinoma. Ann Surg Oncol 2003; 10:447-454. (Pubitemid 40486944)
12. Chakravarty KD, Yeh CN, Jan YY, Chen MF: Factors influencing long-term survival in patients with T3 gallbladder adenocarcinoma. Digestion 2009; 79:151-157.
13. di Sebastiano P, Festa L, Büchler MW, di Mola FF: Surgical aspects in management of hepato-pancreatico-biliary tumors in the elderly. Best Pract Res Clin Gastroenterol 2009; 23:919-923.
14. Furlan A, Ferris JV, Hosseinzadeh K, Borhani AA: Gallbladder carcinoma update: multimodality imaging evaluation, staging, and treatment options. AJR Am J Roentgenol 2008; 191:1440-1447.
15. Gourgiotis S, Kocher HM, Solaini L, et al.: Gallbladder cancer. Am J Surg 2008; 196:252-264. (Pubitemid 351970506)
16. Nanashima A, Sakamoto I, Hayashi T, et al.: Preoperative diagnosis of lymph node metastasis in biliary and pancreatic carcinomas: evaluation of the combination of multi-detector CT and serum CA19-9 level. Dig Dis Sci 2010; 55(12):3617-3626.
17. Noji T, Kondo S, Hirano S, Tanaka E, Suzuki O, Shichinohe T: Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg 2008; 95:92-96. (Pubitemid 351184920)
18. Furukawa H, Ikuma H, Asakura-Yokoe K, Uesaka K: Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET: prospective comparison with PET+CT, MDCT and histopathology. Eur Radiol 2008; 8:2841-2847.
19. Kaneoka Y, Yamaguchi A, Isogai M, Harada T, Suzuki M: Hepatoduodenal ligament invasion by gallbladder carcinoma: histological patterns and surgical recommendation. World J Surg 2003; 27:260-265. (Pubitemid 36920134)
20. Foster JM, Hoshi H, Gibbs JF, et al.: Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol 2007; 14:833-840. (Pubitemid 46175334)
21. Shukla VK, Gurubachan, Sharma D, Dixit VK, Usha: Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder. Trop Gastroenterol 2006; 27:160-165.
22. Nanashima A, Sumida Y, Tobinaga S, et al.: Characteristics of bile duct carcinoma with superficial extension in the epithelium. World J Surg 2009; 33:1255-1258.
23. Wakai T, Shirai Y, Sakata J, et al.: Mode of hepatic spread from gallbladder carcinoma: an immunohistochemical analysis of 42 hepatectomized specimens. Am J Surg Pathol 2010; 34:65-74.
24. Aramaki M, Matsumoto T, Shibata K, et al.: Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. Hepato-gastroenterol 2004; 51:1609-1611. (Pubitemid 39389742)
25. Yamaguchi R, Nagino M, Oda K, Kamiya J, Uesaka K, Nimura Y: Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg 2002; 89:1130-1136. (Pubitemid 34989219)
26. Shimizu H, Kimura F, Yoshidome H, et al.: Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepatobiliary Pancreat Surg 2007; 14:358-365. (Pubitemid 47190055)
27. Chen MH, Wei Y, Van K, et al.: Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol 2006; 17:671-683. (Pubitemid 44392016)
28. Morise Z, Sugioka A, Tanahashi Y, et al.: Treatment of patients with unresectable advanced carcinoma of biliary tract - chemotherapy and surgical resection. Anticancer Res 2009; 29:1783-1786.